Flurazepam (Dalmane).
D014151:Anti-Anxiety Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005479:Flurazepam / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D006207:Half-Life; D006801:Humans; D007319:Sleep Initiation and Maintenance Disorders / Q000188:drug therapy*; D012894:Sleep Stages; D019966:Substance-Related Disorders / Q000209:etiology
D014151:Anti-Anxiety Agents; D005479:Flurazepam